BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bradi AC, Audisho N, Casey DK, Chapman KR. Alpha-1 antitrypsin deficiency in Canada: regional disparities in diagnosis and management. COPD 2015;12 Suppl 1:15-21. [PMID: 25938286 DOI: 10.3109/15412555.2015.1021908] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Blanco I. Clinical Diagnosis. Blanco's Overview of Alpha-1 Antitrypsin Deficiency. Elsevier; 2017. pp. 115-28. [DOI: 10.1016/b978-0-12-809530-0.00009-x] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Quinn M, Ellis P, Pye A, Turner AM. Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current Perspectives. Ther Clin Risk Manag 2020;16:1243-55. [PMID: 33364772 DOI: 10.2147/TCRM.S234377] [Reference Citation Analysis]
3 Estey MP, Tahooni T, Nelson TN, Parker ML, Agbor TA, Yang HM, Jen R, Barakauskas VE, Lam GY, Matthews A, Mattman A. Is the diagnostic rate for the common subtypes of A1AT deficiency consistent across two Canadian Provinces? Clin Biochem 2021;95:84-8. [PMID: 33964271 DOI: 10.1016/j.clinbiochem.2021.05.002] [Reference Citation Analysis]
4 Sandhaus RA. Foreword. Ther Adv Chronic Dis 2021;12_suppl:2040622320974875. [PMID: 34408827 DOI: 10.1177/2040622320974875] [Reference Citation Analysis]
5 Stoller JK. Detecting Alpha-1 Antitrypsin Deficiency. Annals ATS 2016;13:S317-25. [DOI: 10.1513/annalsats.201506-349kv] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
6 Horváth I, Canotilho M, Chlumský J, Chorostowska-Wynimko J, Corda L, Derom E, Ficker JH, Kneussl M, Miravitlles M, Sucena M, Thabut G, Turner AM, van 't Wout E, McElvaney NG. Diagnosis and management of α1-antitrypsin deficiency in Europe: an expert survey. ERJ Open Res 2019;5:00171-2018. [PMID: 30863774 DOI: 10.1183/23120541.00171-2018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
7 Maltais F, Gaudreault N, Racine C, Thériault S, Bossé Y. Clinical Experience with SERPINA1 DNA Sequencing to Detect Alpha-1 Antitrypsin Deficiency. Annals ATS 2018;15:266-8. [DOI: 10.1513/annalsats.201708-694rl] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
8 Bernhard N, Lepper PM, Vogelmeier C, Seibert M, Wagenpfeil S, Bals R, Fähndrich S. Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry. Int J Chron Obstruct Pulmon Dis 2017;12:1427-37. [PMID: 28553095 DOI: 10.2147/COPD.S130925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
9 Soriano JB, Mahadeva R. α 1 -Antitrypsin deficiency: count me in please! Eur Respir J 2017;49:1601941. [DOI: 10.1183/13993003.01941-2016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Hatipoğlu U, Stoller JK. α1-Antitrypsin Deficiency. Clin Chest Med 2016;37:487-504. [PMID: 27514595 DOI: 10.1016/j.ccm.2016.04.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]